Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy

Strahlentherapie und Onkologie

Volumn 182, Issue 5, 2006, Pages 277-282

  Boehmer, Dirk ^a   Kuczer, David ^a   Badakhshi, Harun ^a   Stiefel, Simone ^a   Kuschke, Wolf ^a   Wernecke, Klaus Dieter ^a   Budach, Volker ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Dose volume histogram; Organ at risk definition; Prostate cancer; Radiotherapy; Rectal contouring

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DOSE VOLUME HISTOGRAM; EQUIPMENT; EXTERNAL BEAM RADIOTHERAPY; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RADIATION DOSE; RANK SUM TEST; RECTUM; RECTUM HEMORRHAGE; RISK ASSESSMENT; VOLUMETRY;

DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RECTUM; RISK FACTORS; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646552695     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1462-7     Document Type: Article

References (38)

1. Beckendorf V, Guerif S, Le Prise E, et al. The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity. Int J Radiat Oncol Biol Phys 2004;60:1056-65.
2. Chism DB, Horwitz EM, Hanlon AL, et al. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys 2003;55:71-7.
3. Dale E, Olsen DR, Fossa SD. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys 1999;43:385-91.
4. De Meerleer GO, Vakaet LA, De Gersem WR, et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000;47:639-48.
5. De Meerleer GO, Villeirs GM, Vakaet L, et al. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer. Strahlenther Onkol 2004;180:573-81.
6. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
7. Fiorino C, Cozzarini C, Vavassori V, et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 2002;64:1-12.
8. Geinitz H, Zimmermann FB, Narkwong L, et al. [Prostatic carcinoma: problems in the interpretation of rectal dose-volume histograms.] Strahlenther Onkol 2000;176:168-72.
9. Gerstner N, Wachter S, Dorner D, et al. [Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma.] Strahlenther Onkol 1999;175:232-8.
10. Greco C, Mazzetta C, Cattani F, et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. Radiother Oncol 2003;69:215-22.
11. Hahn P, Baral E, Cheang M, et al. Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987. Int J Radiat Oncol Biol Phys 1996;34:41-7.
12. Hille A, Schmidberger H, Tows N, et al. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol 2005;181:709-16.
13. Hille A, Tows N, Schmidberger H, et al. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio. Strahlenther Onkol 2005;181:789-95.
14. Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:1314-21.
15. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report 50. Bethesda: ICRU, 1993.
16. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report 62. Bethesda: ICRU, 1999.
17. Karlsdottir A, Johannessen DC, Muren LP, et al. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiother Oncol 2004;71:43-53.
18. Koper PC, Heemsbergen WD, Hoogeman MS, et al. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2004;58:1072-82.
19. Koper PC, Jansen P, van Putten W, et al. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial. Radiother Oncol 2004;73:1-9.
20. Kupelian PA, Reddy CA, Carlson TP, et al. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume? Cancer J 2002;8:62-6.
21. Livsey JE, Wylie JP, Swindell R, et al. Do differences in target volume definition in prostate cancer lead to clinically relevant differences in normal tissue toxicity? Int J Radiat Oncol Biol Phys 2004;60:1076-81.
22. Lu Y, Li S, Spelbring D, et al. Dose-surface histograms as treatment planning tool for prostate conformal therapy. Med Phys 1995;22:279-84.
23. Lu Y, Song PY, Li SD, et al. A method of analyzing rectal surface area irradiated and rectal complications in prostate conformal radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:1121-5.
24. Michalski JM, Purdy JA, Winter K, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000;46:391-402.
25. Miralbell R, Taussky D, Rinaldi O, et al. Influence of rectal volume changes during radiotherapy for prostate cancer: a predictive model for mild-to-moderate late rectal toxicity. Int J Radiat Oncol Biol Phys 2003;57:1280-4.
26. Mock U, Bogner J, Georg D, et al. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy. Strahlenther Onkol 2005;181:448-55.
27. Nuyttens JJ, Milito S, Rust PF, et al. Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 2002;64:209-14.
28. Peeters ST, Heemsbergen WD, van Putten WL, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 2005;61:1019-34.
29. Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002;53:1097-105.
30. Rubin P. Radiation toxicology: quantitative radiation pathology for predicting effects. Cancer 1977;39:729-36.
31. Sanguineti G, Castellone P, Foppiano F, et al. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder. Strahlenther Onkol 2004;180:563-72.
32. Schulte RW, Slater JD, Rossi CJ Jr, et al. Value and perspectives of proton radiation therapy for limited stage prostate cancer. Strahlenther Onkol 2000;176:3-8.
33. Schultheiss TE, Hanks GE, Hunt MA, et al. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1995;32:643-9.
34. Storey MR, Pollack A, Zagars G, et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-42.
35. Teh BS, Dong L, McGary JE, et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim 2005;30:25-30.
36. Tucker SL, Dong L, Cheung R, et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:1589-601.
37. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:91-100.
38. Wachter S, Gerstner N, Goldner G, et al. Three dimensional conformal photon radiotherapy at a moderate dose level of 66 Gy for prostate carcinoma: early results. Strahlenther Onkol 1999;175:Suppl 2:84-6.